Paper · 32899298
Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
Bradfield A and 5 others. Methods Protoc, 2020. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer. Papers, record 32899298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32899298
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/P020941/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References226
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,141,961 | Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27141961 | PubMed |
| 2 | 27,323,951 | Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. | Genome Med | 2016 | https://conductscience.org/library/papers/27323951 | PubMed |
| 3 | 23,612,453 | Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. | Br J Cancer | 2013 | https://conductscience.org/library/papers/23612453 | PubMed |
| 4 | 16,181,779 | Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity. | Eur J Cancer | 2005 | https://conductscience.org/library/papers/16181779 | PubMed |
| 5 | 31,743,514 | Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders. | Cancer Sci | 2020 | https://conductscience.org/library/papers/31743514 | PubMed |
| 6 | 28,418,882 | Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/28418882 | PubMed |
| 7 | 12,444,098 | The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. | Hum Mol Genet | 2002 | https://conductscience.org/library/papers/12444098 | PubMed |
| 8 | 1,670,908 | Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. | Am J Obstet Gynecol | 1991 | https://conductscience.org/library/papers/1670908 | PubMed |
| 9 | 12,242,432 | BLM heterozygosity and the risk of colorectal cancer. | Science | 2002 | https://conductscience.org/library/papers/12242432 | PubMed |
| 10 | 11,748,987 | Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. | Gynecol Oncol | 2002 | https://conductscience.org/library/papers/11748987 | PubMed |
1 to 10 of 226
See all 226 referencesCited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,515,119 | A prognostic model for Schistosoma japonicum infection-associated liver hepatocellular carcinoma: strengthening the connection through initial biological experiments. | Infect Agent Cancer | 2024 | https://conductscience.org/library/papers/38515119 | PubMed |
| 38,425,244 | TRMT13 inhibits the growth of papillary thyroid cancer by targeting ANAPC4. | Acta Biochim Biophys Sin (Shanghai) | 2024 | https://conductscience.org/library/papers/38425244 | PubMed |
| 37,141,817 | Detection of endometrial cancer using tampon-based collection and methylated DNA markers. | Gynecol Oncol | 2023 | https://conductscience.org/library/papers/37141817 | PubMed |
| 35,682,908 | Role of Nucleolin in Endometrial Precancerous Hyperplasia and Carcinogenesis: Ex Vivo and In Silico Study. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682908 | PubMed |
| 35,054,812 | Telomere and Telomerase-Associated Proteins in Endometrial Carcinogenesis and Cancer-Associated Survival. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35054812 | PubMed |
| 34,412,690 | Mutual regulation between chicken telomerase reverse transcriptase and the Wnt/β-catenin signalling pathway inhibits apoptosis and promotes the replication of ALV-J in LMH cells. | Vet Res | 2021 | https://conductscience.org/library/papers/34412690 | PubMed |
| 33,317,189 | Endometriosis Is Associated with a Significant Increase in hTERC and Altered Telomere/Telomerase Associated Genes in the Eutopic Endometrium, an Ex-Vivo and In Silico Study. | Biomedicines | 2020 | https://conductscience.org/library/papers/33317189 | PubMed |
| 33,217,925 | Human Endometrial Carcinogenesis Is Associated with Significant Reduction in Long Non-Coding RNA, TERRA. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33217925 | PubMed |
Genes106
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACD | 65,057 | PubTator's text mining | https://conductscience.org/library/genes/65057 | NCBI Gene |
| AIM2 | 9,447 | PubTator's text mining | https://conductscience.org/library/genes/9447 | NCBI Gene |
| ANAPC4 | 29,945 | PubTator's text mining | https://conductscience.org/library/genes/29945 | NCBI Gene |
| ARHGAP20 | 57,569 | PubTator's text mining | https://conductscience.org/library/genes/57569 | NCBI Gene |
| ARL4C | 10,123 | PubTator's text mining | https://conductscience.org/library/genes/10123 | NCBI Gene |
| ATAD2 | 29,028 | PubTator's text mining | https://conductscience.org/library/genes/29028 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| AURKA | 6,790 | PubTator's text mining | https://conductscience.org/library/genes/6790 | NCBI Gene |
| BIRC5 | 332 | PubTator's text mining | https://conductscience.org/library/genes/332 | NCBI Gene |
| BLM | 641 | PubTator's text mining | https://conductscience.org/library/genes/641 | NCBI Gene |
1 to 10 of 106
See all 106 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32899298
GET https://conductscience.org/api/papers/v1/32899298/references?page=2